Bisphosphonates linked to atrial fibrillation

Article

Bisphosphonate therapy for osteoporosis may increase the risk of serious atrial fibrillation, which can result in hospitalization or death, according to research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians, in Philadelphia.

Bisphosphonate therapy for osteoporosis may increase the risk of serious atrial fibrillation, which can result in hospitalization or death, according to research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians, in Philadelphia.

Jennifer Miranda, MD, of Jackson Memorial Hospital in Miami and colleagues conducted a meta-analysis of three trials involving 16,322 mostly female patients (mean age range 69-75) who received either alendronate or zoledronic acid or placebo.

In patients taking bisphosphonates, the researchers found that 2.5% to 3% experienced atrial fibrillation and that 1% to 2% experienced serious atrial fibrillation. They found that bisphosphonates were associated with an increased risk of both incident and serious atrial fibrillation (OR 1.19 and 1.68, respectively).

“The mechanism, population at risk and the impact of this important adverse event should be further evaluated in studies and be weighed against the benefit of decreased fracture risk,” the authors write.http://accp.scientificabstracts.org/epsAbstract.cfm?id=6

Recent Videos
Eran Bornstein, MD, highlights early signs of preeclampsia clinicians need to know | Image Credit: northwell.edu.
Eran Bornstein, MD explains the need for first trimester preeclampsia screening | Image Credit: northwell.edu.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis | Image Credit: profiles.mountsinai.org.
Ivie Odiase, MD
Susan Khalil, MD
Sharon Erdrich, PhD, discusses why oral health should be routine in health care | Image Credit: linkedIn.com.
Sharon Erdrich, PhD, highlights oral health's impact on chronic pain | Image Credit: linkedIn.com.
Fiona Gilbert, MA, MB, discusses breast cancer screening for dense breasts | Image Credit: newn.cam.ac.uk
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.